{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T11:18:13Z","timestamp":1753183093158,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T00:00:00Z","timestamp":1595030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T00:00:00Z","timestamp":1595030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The long-term mortality in giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) is unexpectedly decreased or at least not increased regardless of several mortality risk factors that these diseases share with other chronic immune-mediated rheumatic diseases. The genetic and immunological profile of PMR\/GCA patients is unique, therefore, the hypothesis that this profile provides some survival advantage to PMR\/GCA patients should be considered. The longevity is a phenomenon that was demonstrated to be familial. The familial aggregation of longevity can be studied by analysis of life expectancy in family members. Here we test the hypothesis of the aggregation of an increased longevity in the families of PMR\/GCA patients. We compared the age of death of 358 parents of 179 PMR and GCA patients with corresponding data retrieved from 506 parents of 253 randomly collected age and sex-matched controls. The number of nonagenarian (\u2265\u200990-year -old) mothers of PMR\/GCA patients was significantly higher (OR\u2009=\u20092.34, 95%CI 1.11\u201311.95, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0005) vs controls. Both nonagenarian parents were found in 6 patients (3.35%) and none in the control cohort (OR\u2009=\u20098.77, 95%CI 2.26\u2013405.10, <jats:italic>p<\/jats:italic>\u2009=\u20090.003). Our data suggest the familial aggregation of nonagenarians in PMR\/GCA patients.<\/jats:p>","DOI":"10.1007\/s00296-020-04649-7","type":"journal-article","created":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T10:02:32Z","timestamp":1595066552000},"page":"2071-2075","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0943-8768","authenticated-orcid":false,"given":"Marcin","family":"Milchert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7681-4367","authenticated-orcid":false,"given":"Marek","family":"Brzosko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,18]]},"reference":[{"key":"4649_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.semarthrit.2016.08.015","volume":"46","author":"CL Hill","year":"2017","unstructured":"Hill CL, Black RJ, Nossent JC et al (2017) Risk of mortality in patients with giant cell arteritis: a systematic review and meta-analysis. Semin Arthritis Rheum 46:513\u2013519. https:\/\/doi.org\/10.1016\/j.semarthrit.2016.08.015","journal-title":"Semin Arthritis Rheum"},{"key":"4649_CR2","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1093\/rheumatology\/40.11.1238","volume":"40","author":"JT Gran","year":"2001","unstructured":"Gran JT, Myklebust G, Wilsgaard T et al (2001) Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology 40:1238\u20131242. https:\/\/doi.org\/10.1093\/rheumatology\/40.11.1238","journal-title":"Rheumatology"},{"key":"4649_CR3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1136\/annrheumdis-2013-204652","volume":"74","author":"AJ Mohammad","year":"2015","unstructured":"Mohammad AJ, Nilsson JA, Jacobsson LT et al (2015) Incidence and mortality rates of biopsy proven giant cell arteritis in southern Sweden. Ann Rheum Dis 74:993\u2013997. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204652","journal-title":"Ann Rheum Dis"},{"key":"4649_CR4","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1016\/S0002-9343(97)89458-2","volume":"100","author":"EL Matteson","year":"1996","unstructured":"Matteson EL, Gold KN, Bloch DA et al (1996) Long-term survival of patients with giant cell arteritis in the American college of rheumatology giant cell arteritis classification criteria cohort. Am J Med 100:1936. https:\/\/doi.org\/10.1016\/S0002-9343(97)89458-2","journal-title":"Am J Med"},{"key":"4649_CR5","doi-asserted-by":"publisher","first-page":"22157","DOI":"10.3899\/jrheum.101254","volume":"38","author":"J Ninan","year":"2011","unstructured":"Ninan J, Nguyen AM, Cole A et al (2011) Mortality in patients with biopsy-proven giant cell arteritis: a South Australian population-based study. J Rheumatol 38:22157. https:\/\/doi.org\/10.3899\/jrheum.101254","journal-title":"J Rheumatol"},{"key":"4649_CR6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/rheumatology\/key285","volume":"58","author":"T Garen","year":"2019","unstructured":"Garen T, Lerang K, Hoffmann-Vold AM et al (2019) Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides. Rheumatol (Oxford) 58:313\u2013320. https:\/\/doi.org\/10.1093\/rheumatology\/key285","journal-title":"Rheumatol (Oxford)"},{"key":"4649_CR7","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.0954-6820.1981.tb11604.x","volume":"209","author":"BA Bengtsson","year":"1981","unstructured":"Bengtsson BA, Malmvall BE (1981) Prognosis of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. a follow-up study on ninety patients treated with corticosteroids. Acta Med Scand 209:337\u2013345. https:\/\/doi.org\/10.1111\/j.0954-6820.1981.tb11604.x","journal-title":"Acta Med Scand"},{"key":"4649_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.0954-6820.1986.tb02778.x","volume":"220","author":"R Andersson","year":"1986","unstructured":"Andersson R, Malmvall BE, Bengtsson BA (1986) Long-term survival in giant cell arteritis including temporal arteritis and polymyalgia rheumatica. A follow-up study of 90 patients treated with corticosteroids. Acta Med Scand 220:361\u2013364. https:\/\/doi.org\/10.1111\/j.0954-6820.1986.tb02778.x","journal-title":"Acta Med Scand"},{"key":"4649_CR9","first-page":"21716","volume":"24","author":"MA Gonzalez-Gay","year":"1997","unstructured":"Gonzalez-Gay MA, Blanco R, Abraira V et al (1997) Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality. J Rheumatol 24:21716","journal-title":"J Rheumatol"},{"key":"4649_CR10","first-page":"737","volume":"29","author":"A Uddhammar","year":"2002","unstructured":"Uddhammar A, Eriksson AL, Nystr\u00f6m L et al (2002) Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol 29:737\u2013742","journal-title":"J Rheumatol"},{"key":"4649_CR11","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1093\/gerona\/gln030","volume":"64","author":"RW Crow","year":"2009","unstructured":"Crow RW, Katz BJ, Warner JE et al (2009) Giant cell arteritis and mortality. J Gerontol A Biol Sci Med Sci 64:3659. https:\/\/doi.org\/10.1093\/gerona\/gln030","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"4649_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/rheumatology\/keu303","volume":"54","author":"B Baslund","year":"2015","unstructured":"Baslund B, Helleberg M, Faurschou M et al (2015) Mortality in patients with giant cell arteritis. Rheumatol (Oxford) 54:139\u2013143. https:\/\/doi.org\/10.1093\/rheumatology\/keu303","journal-title":"Rheumatol (Oxford)"},{"key":"4649_CR13","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/rheumatology\/keu483","volume":"54","author":"S Unizony","year":"2015","unstructured":"Unizony S, Menendez ME, Rastalsky N et al (2015) Inpatient complications in patients with giant cell arteritis: decreased mortality and increased risk of thromboembolism, delirium and adrenal insufficiency. Rheumatol (Oxford) 54:1360\u20131368. https:\/\/doi.org\/10.1093\/rheumatology\/keu483","journal-title":"Rheumatol (Oxford)"},{"key":"4649_CR14","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/03009740310000382","volume":"32","author":"G Myklebust","year":"2003","unstructured":"Myklebust G, Wilsgaard T, Jacobsen BK et al (2003) Causes of death in polymyalgia rheumatica. A prospective longitudinal study of 315 cases and matched population controls. Scand J Rheumatol 32:38\u201341. https:\/\/doi.org\/10.1080\/03009740310000382","journal-title":"Scand J Rheumatol"},{"key":"4649_CR15","doi-asserted-by":"publisher","first-page":"e297","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle D, McDermott MF (2006) A proposed classification of the immunological diseases. PLoS Med 3:e297. https:\/\/doi.org\/10.1371\/journal.pmed.0030297","journal-title":"PLoS Med"},{"key":"4649_CR16","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/sj.ejhg.5201308","volume":"13","author":"AK Niemi","year":"2005","unstructured":"Niemi AK, Moilanen JS, Tanaka M et al (2005) A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects. Eur J Hum Genet 13:166\u2013170. https:\/\/doi.org\/10.1038\/sj.ejhg.5201308","journal-title":"Eur J Hum Genet"},{"key":"4649_CR17","doi-asserted-by":"publisher","first-page":"412","DOI":"10.18632\/aging.100763","volume":"7","author":"JA Deluty","year":"2015","unstructured":"Deluty JA, Atzmon G, Crandall J et al (2015) The influence of gender on inheritance of exceptional longevity. Aging (Albany NY) 7:412\u2013418. https:\/\/doi.org\/10.18632\/aging.100763","journal-title":"Aging (Albany NY)"},{"key":"4649_CR18","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.jacc.2016.05.072","volume":"68","author":"JL Atkins","year":"2016","unstructured":"Atkins JL, Pilling LC, Ble A et al (2016) Longer-lived parents and cardiovascular outcomes: 8-year follow-up in 186,000 UK. Biobank Participants J Am Coll Cardiol 68:874\u2013875. https:\/\/doi.org\/10.1016\/j.jacc.2016.05.072","journal-title":"Biobank Participants J Am Coll Cardiol"},{"unstructured":"https:\/\/www.sejm-wielki.pl\/. Accessed 1 June 2019","key":"4649_CR19"},{"key":"4649_CR20","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/art.1780330802","volume":"33","author":"GG Hunder","year":"1990","unstructured":"Hunder GG, Arend WP, Bloch DA et al (1990) The american college of rheumatology 1990 criteria for the classification of vasculitis. Introduction Arthritis Rheum 33:1065\u20131067. https:\/\/doi.org\/10.1002\/art.1780330802","journal-title":"Introduction Arthritis Rheum"},{"key":"4649_CR21","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/annrheumdis-2011-200329","volume":"71","author":"B Dasgupta","year":"2012","unstructured":"Dasgupta B, Cimmino MA, Maradit-Kremers H et al (2012) 2012 provisional classification criteria for polymyalgia rheumatica: a European league against rheumatism\/American college of rheumatology collaborative initiative. Ann Rheum Dis 71:484\u2013492. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200329","journal-title":"Ann Rheum Dis"},{"key":"4649_CR22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/acr.22416","volume":"67","author":"PD Udayakumar","year":"2015","unstructured":"Udayakumar PD, Chandran AK, Crowson CS et al (2015) Cardiovascular risk and acute coronary syndrome in giant cell arteritis: a population-based retrospective cohort study. Arthritis Care Res (Hoboken) 67:396\u2013402. https:\/\/doi.org\/10.1002\/acr.22416","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-020-04649-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-020-04649-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T23:23:11Z","timestamp":1626564191000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-020-04649-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,18]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4649"],"URL":"https:\/\/doi.org\/10.1007\/s00296-020-04649-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2020,7,18]]},"assertion":[{"value":"3 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declared that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"Local ethical committee decision KB-0012\/170\/06\/19.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human participants"}},{"value":"The study was accepted and patients\u2019 consent was waived in accordance with Pomeranian Medical University ethical committee decision KB-0012\/170\/06\/19.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}